Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1994-03-23
1996-04-02
Cintins, Marianne M.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
514378, 514521, 514861, 514863, A61K 31535, A61K 3142, A61K, A61K
Patent
active
055040845
ABSTRACT:
Pharmaceutical for the treatment of skin disorders
A compound of the formula I or II ##STR1## and physiologically tolerable salts of compound of the formula II are suitable for treatment of psoriasis.
REFERENCES:
patent: 4061767 (1977-12-01), Ertel et al.
patent: 4351841 (1982-09-01), Kammerer et al.
patent: 5001124 (1991-03-01), Patterson et al.
patent: 5240960 (1993-08-01), Hambleton et al.
patent: 5268382 (1993-12-01), Bartlett et al.
Chemical Abstracts (93:239393n) 1980.
Chemical Abstracts, vol. 115, 1991, p. 452, No. 115:1563ly.
Borel et al., Transplantation Proceedings, vol. 23, No. 2 (April), 1991:pp. 1867-1874.
Mason, Pharmacological Reviews, vol. 42, No. 3, 1989, pp. 423-434.
Hambleton and McMahon, "Drug Actions on Delayed-Type Hypersensitivity in Rats with Developing and Established Adjuvant Arthritis," Agents and Actions, vol. 29, 3/4 (1990), pp. 328-332.
Bartlett et al., "Effects of Lefluonomide on Immune Responses and Models of Inflammation," Springer Semin Immunopathol, (1993) 14:381-394.
Bartlett et al., "Lefluonomide (HWA) 486), a Novel Immunomodulating Compound for the Treatment of Autoimmune Disorders and Reactions Leading to Transplantation Rejection," Agents and Actions, vol. 32, 1/2 (1991) pp. 10-21.
FASEB, vol. 4, No. 7, 1990, No. 2966.
Levitzki and Gilon, "Tryphostins as Molecular Tools and Potential Anti-proliferative drugs," Trends in Pharmaceutical Sciences, vol. 12, No. 5, 1991, pp. 171-174.
King and Stoscheck, "Epidermal Growth Factor: Its Relevance to Dermatology," J. Toxicol.-Cut. & Ocular Toxicol. 8(4), 411-416 (1989-1990).
Scholemmer et al., "Prolongation of Allogeneic Transplanted Skin Grafts and Induction of Tolerance by Lefluonomide, a New Immunosuppresive Isoxazol Derivative," Transplantation Proceedings, vol. 25, No. 1, Feb. 1993, pp. 763-767.
Enqst et al., "Stellenwert Immunsuppressiv Wirkender Pharmaka In Der Antipsoriatischen Therapie," Zeitschrift Fur Hautkrankheiten, vol. 66, No. 2, 1991, pp. 55-60.
Bartlett Robert R.
Kurtz Ellen S.
Weithmann Klaus U.
Cintins Marianne M.
Hoechst Aktiengesellschaft
Hoechst-Roussel Pharmaceuticals Inc.
Weddington K.
LandOfFree
Pharmaceutical for the treatment of skin disorders does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pharmaceutical for the treatment of skin disorders, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical for the treatment of skin disorders will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2016456